BBIO BridgeBio Pharma, Inc.

$72.44▼ -0.08% Healthcare Other
After hours $72.44▲ +0.00% Sep 11, 7:57 PM ET
Volume 1.77M Avg Volume (10D) 1.82M
Key Metrics & Fundamentals
Market Cap
$14.16B
P/E Ratio
–
Div Yield
–%
52W Range
48.78 - 93.42
% vs 50 MA
-10.23%
% vs 200 MA
-2.11%
RSI-14
29.9
MACD Histogram
-0.6800
Beta (1Y vs SPY)
1.14
Free Cash Flow
-$71.54M
Gross Rev
$243.68M
Gross Profit
$228.63M
EBITDA
-$105.80M
COGS
$15.05M
Operating Exp
$335.71M
Operating Income
-$107.08M
EBIT
-$107.08M
Pretax Income
-$155.89M
Net Income
-$152.22M
EPS (Diluted)
-0.78
Price & Volume History
Loading chart…
Recent News
BridgeBio Pharma (BBIO) Down 10.7% Since Last Earnings Report: Can It Rebound?
Zacks · Sep 9, 2026 3:30 PM
Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial
GlobeNewswire · Sep 9, 2026 8:00 AM
BridgeBio (BBIO) Reported Signs of Cardiac Reversal With Acoramidis. How Much Weight Should Investors Give a Completer Analysis?
Insider Monkey · Sep 4, 2026 4:18 PM
How BioMarin Turned a Competitive Threat Into a Royalty-Bearing Asset
Zacks · Sep 3, 2026 4:28 PM
Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President
Benzinga · Sep 2, 2026 10:00 PM
BridgeBio to Present New Data on the Impact of Oral Infigratinib on Medical Complications in Achondroplasia at the Annual ESPE Meeting 2026
GlobeNewswire · Sep 2, 2026 11:30 AM
What Does BridgeBio Pharma (BBIO) Gain From Its New US Drug Access Deal?
Simply Wall St. · Sep 1, 2026 8:13 PM
Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers
Zacks · Sep 1, 2026 4:35 PM
4 Rare Disease Drugmakers With Strong Long-Term Growth Prospects
Zacks · Sep 1, 2026 2:56 PM
Mid-cap biotechs join Trump’s latest round of drug pricing deals
BioPharma Dive · Sep 1, 2026 12:14 PM
Financial Overview - Income Statement Quarterly

See BBIO's money flow as a full page

Social Sentiment
Avg +0.70 · 3 posts
TradePriceTargetBBIO at 47 Break out soon
r/wallstreetbets · Aug 5, 2025
The post expresses optimism about BBIO's future price, indicating a bullish sentiment.
positive +0.60
NewsDiscussion🧬 5 Biotech Catalysts I’m Watching This Month — May 18–30
r/StockMarket · May 17, 2025
Focus on a positive Phase 3 readout with a high probability of success.
positive +0.70
TradeDiscussionGain BBIO
r/wallstreetbets · Jan 13, 2025
The author expresses a 'nice choice' and anticipates similar success, indicating a bullish sentiment.
positive +0.80
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙